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Abstract
Background: To evaluate the metabolic effects of two weight loss diets differing in macronutrient
composition on features of dyslipidemia and post-prandial insulin (INS) response to a meal
challenge in overweight/obese individuals.
Methods: This study was a parallel-arm randomized 4 mo weight loss trial. Adults (n = 50, 47 ± 7
y) matched on BMI (33.6 ± 0.6 kg/m2, P = 0.79) consumed energy restricted diets (deficit ~500 kcal/
d): PRO (1.6 g.kg-1.d-1 protein and < 170 g/d carbohydrate) or CHO (0.8 g.kg-1.d-1 protein and >
220 g/d carbohydrate) for 4 mos. Meal challenges of respective diets were utilized for
determination of blood lipids and post-prandial INS and glucose response at the beginning and end
of the study.
Results: There was a trend for PRO to lose more weight (-9.1% vs. -7.3%, P = 0.07) with a
significant reduction in percent fat mass compared to CHO (-8.7% vs. -5.7%; P = 0.03). PRO also
favored reductions in triacylglycerol (-34% vs. -14%; P < 0.05) and increases in HDL-C (+5% vs. -
3%; P = 0.05); however, CHO favored reduction in LDL-C (-7% vs. +2.5%; P < 0.05). INS responses
to the meal challenge were improved in PRO compared to CHO (P < 0.05) at both 1 hr (-34.3%
vs. -1.0%) and 2 hr (-9.2% vs. +46.2%), an effect that remained significant after controlling for weight
or fat loss (both P < 0.05).
Conclusion: A weight loss diet with moderate carbohydrate, moderate protein results in more
favorable changes in body composition, dyslipidemia, and post-prandial INS response compared to
a high carbohydrate, low protein diet suggesting an additional benefit beyond weight management
to include augmented risk reduction for metabolic disease.
Introduction
Obesity is a significant risk factor for cardiovascular dis-
ease (CVD) [1,2]. The risk, at least in part, is related to
abnormal blood lipids consisting of elevated triacylglycer-
ides (TAG), low high density lipoprotein cholesterol
(HDL-C), and small, dense low density lipoprotein cho-
lesterol (LDL-C) particles. This lipid profile is considered
an atherogenic dyslipidemia and recognized as a primary
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feature of Metabolic Syndrome (MetS), an established risk
factor for CVD and type 2 diabetes mellitus (T2DM) [3].
Dyslipidemia and MetS are both associated with high
habitual simple dietary carbohydrate intakes, reduced
insulin (INS) sensitivity, and elevated post-prandial INS
[3-6]. Evidence is accumulating that post-prandial glyc-
emia is an important risk factor for CVD [7,8]. Reaven et
al [4] reported that although hypertriacylglyceridemia is
an essential component of MetS, it is secondary to post-
prandial INS response in risk for CVD. Even in individuals
with normal blood glucose response, post-prandial INS
varied more than 4-fold and the greatest post-prandial
INS responses (i.e. compensatory hyperinsulinemia) had
the highest TAG concentrations. More recently, Krauss et
al [9] reported a linear relationship of carbohydrate intake
and prevalence of atherogenic dyslipidemia in healthy
subjects.
Reducing carbohydrate intake with replacement of either
fat or protein has been shown to reduce TAG and increase
HDL-C even under weight stable conditions [4,9,10]. Sub-
stitution with protein may be more beneficial than fat for
lipid changes [9-13] and improvement in INS action
[5,14,15]. Indeed, independent effects of protein on glyc-
emic regulation [16,17] suggests protein may be a more
effective dietary change than increases in fat intake for
reducing risk for metabolic disease.
In this context, the aim of this study was to compare the
relative efficacy of two weight loss diets differing in
macronutrient content on fasted TAG and post-prandial
INS in response to a meal challenge in overweight or
obese individuals. We compared the conventionally
accepted USDA Food Guide Pyramid diet (CHO) with a
moderate carbohydrate, moderate protein (PRO) diet.
Macronutrients for both dietary treatments fall within the
Acceptable Macronutrient Distribution Range (AMDR)
established by the Institute of Medicine's (IOM) Dietary
Reference Intakes (DRI) [18]. We hypothesized that the
PRO weight loss diet would result in greater fat mass loss
and more favorable changes in post-prandial INS




This study was a parallel-arm randomized 4 mo weight
loss trial. Subjects were blocked on gender, matched on
age (47.2 ± 1.0 y, P = 0.52), BMI (33.6 ± 0.6 kg/m2, P =
0.79) and fasting glucose (5.4 ± 0.1 mmol/L, P = 0.24).
Diet treatments consisted of a PRO diet (carbohydrate
~40%; protein ~30%; fat ~30%) or an isocaloric CHO diet
(carbohydrate ~55%; protein ~15%; fat ~30%).
Subjects
Eighty-seven adults were interviewed for participation.
Sixty-five adults aged 40 to 56 y were enrolled to partici-
pate in the weight loss study. Exclusion criteria were BMI
< 26 kg/m2, body weight > 140 kg [due to dual energy X-
ray absorptometry (DXA) scanning bed constraints],
smoking, any existing medical conditions requiring med-
ications that could impact primary or secondary outcomes
of the study, and use of oral steroids or anti-depression
medications. Reported results are based on n = 50 (M =
19; F = 31), due to either lack of adherence to protocol or
loss to follow-up at 4 mo and one subject started training
for a marathon (n = 15; PRO = 7; CHO = 8). The study was
approved by the Institutional Review Board at the Univer-
sity of Illinois at Urbana-Champaign. All subjects gave
written informed consent prior to participation.
All subjects participated in a baseline evaluation period
that included a 24-h food recall, instructions for weighing
and recording of foods, two 3-d weighed food records dur-
ing separate weeks and measurements of weight, height,
and blood lipids. This evaluation period from first contact
with subjects was 10 to 20 d and served as an initial con-
trol period for each subject. During this baseline period,
subjects were instructed to maintain stable body weight
and consume a diet similar to the past 6 mo. After the
baseline period, subjects reported to the nutrition
research laboratory at 0630 h after a 12 h overnight fast for
weight measurement and blood collection.
Diet Treatments
Similar to our previous studies [11,14,19], the prescribed
CHO diet provided dietary protein at 0.8 g.kg-1.d-1 and >
220 g/d carbohydrate (~15% and ~55% of energy intake
respectively). The prescribed PRO diet provided dietary
protein at 1.6 g.kg-1.d-1 and < 170 g/d carbohydrate (~30%
and ~40% of energy intake respectively). Dietary lipids
were constant between diets (~30% energy intake). These
diets were designed to fall within the AMDR established
by the IOM with minimum intakes for carbohydrates at
130 g/d and protein at 0.8 g.kg-1.d-1 and upper limits for
carbohydrates at 65% and protein at 35% of total energy
intake [18]. The two diets were formulated to be equal in
energy (7100 kJ/d; 1700 kcal/d), total fat intake (~57 g/d)
and fiber (~14 g/1000 kcal-1.d-1). Each group received a
menu plan with meals for each day meeting established
nutritional requirements [18] and dietary lipid guidelines
[20]. Diet differences between groups were designed to
reflect direct substitution of foods in the protein groups
(meats, dairy, eggs and nuts) for foods in the refined
grain/starch groups (breads, rice, cereals, pasta and pota-
toes). Education guidelines for the CHO group followed
USDA MyPyramid [21] and emphasized restricting dietary
fat and cholesterol with use of whole grain breads, rice,
cereals and pasta. For the PRO group, education guide-Nutrition & Metabolism 2008, 5:30 http://www.nutritionandmetabolism.com/content/5/1/30
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lines emphasized use of high quality proteins including
lean meats, dairy and eggs. Both diets included 5 servings/
d of vegetables and 2 to 3 servings/d of fruit.
Education Program and Monitoring
Subjects were provided electronic food scales and
instructed to weigh foods at all meals. Subjects docu-
mented a 3-d weighed food record for each week through-
out the study. Nutrient intakes were evaluated as mean
daily intakes from 3-d weighed records using Nutritionist
Pro software (First DataBank Inc. 2003, San Bruno, CA).
After baseline data collection, subjects received instruc-
tions from a research dietitian about their specific diet
including menus, food substitutions, portion sizes, and
procedures for maintaining weighed diet records.
Throughout the 4 mo study, subjects were required to
attend a 1 h meeting each week at the nutrition research
facility. Meetings were specific for each treatment group
and directed by research dietitians who provided diet and
exercise information and reviewed diet records for treat-
ment compliance. Each week, subjects were weighed in
light clothing without shoes and provided 3-d weighed
food records.
The education program focused on diet compliance with
minimal guidance regarding exercise. Activity guidelines
emphasized lifestyle recommendations for physical activ-
ity based on NIH Guidelines for Weight Management
[22]. These guidelines recommend a minimum of 30 min
of walking 5 d/wk. Participation in physical activity for
the groups was voluntary. Physical activity was monitored
using daily activity logs and 3 d/mo subjects wore arm-
band accelerometers (BodyMedia, Cincinnati, OH). Activ-
ity logs were collected each week. Records indicated that
subjects exercised ~90 min/wk with no difference between
diet treatment groups (P > 0.05).
Body Weight and Composition
Body weight was measured using an electronic scale (Tan-
ita, Model BWB-627A, Tokyo Japan). Whole body compo-
sition was determined by DXA (Hologic, QDR4500A,
Bedford MA) and scans for a given individual were ana-
lyzed by the same technician using standard manufacturer
guidelines. The CVs for DXA outcomes of interest in our
laboratory are ~1.5%.
Meal Challenge and Blood Measurements
Subjects came to the nutrition research facility after a 12 h
fast at baseline and 4 mo for venous collection of fasted
and 1 h and 2 h post-prandial blood. At baseline, all sub-
jects consumed the CHO meal challenge (energy =
1656.77 kJ, protein = 15.32 g, carbohydrate = 55.35 g,
lipid = 13.33 g, saturated fatty acid (SFA) = 7.63 g, choles-
terol = 38 mg, and fiber = 2.93 g) that resembled their pre-
study dietary composition. After 4 mo treatment and
adaptation to the diets, subjects consumed the meal chal-
lenge of their respective diet treatments, i.e. CHO (com-
position listed above) or PRO (energy = 1662.94 kJ,
protein = 33.24 g, carbohydrate = 28.18 g, lipid = 16.57 g,
SFA = 7.26 g, cholesterol = 307.41 mg, and fiber = 1.05 g).
Serum total cholesterol (TC), HDL-C and TAG were deter-
mined by standardized methods [23] by Washington Uni-
versity School of Medicine Core Laboratory for Clinical
Studies (St. Louis, MO) with LDL-C calculated using the
Friedewald equation [24]. Plasma insulin (MP Biomedi-
cals, Irvine, CA; catalog # 07260105) was determined by
a commercial RIA kit. Plasma glucose (ThermoTrace,
Noble Park, Victoria AUS; catalogue # TR15498) was
determined by glucose oxidase. The intra-assay CVs for
insulin and glucose were 5.5% and 1.5% respectively.
Statistics
The primary dependent variable in this study was change
in 2 h post-prandial INS; therefore we determined our sta-
tistical power using this outcome. Previous work in our
laboratory [14,25] determined INS responses to a meal
challenge in the PRO group were reduced by 85% whereas
the CHO group was reduced by 50% (and effect size
between groups of ~1.0) in response to 10 weeks of
weight loss. With this anticipated effect size, an alpha (sig-
nificance) level of 0.05 and a power of 90%, a sample size
of 22 subjects per group would be required to find statis-
tical differences in 2 h post-prandial INS between the PRO
and CHO groups should it exist. Given an estimated
retention rate of 75% based on previous weight loss stud-
ies, it was planned to recruit a minimum of 60 individuals
into the study. Differences among groups at baseline were
evaluated using a t-test. Primary outcome variables were
post-prandial INS and TAG. All other evaluated data were
secondary outcomes of interest. Log transformations of
INS and TAG concentrations were used to acquire normal
distributions. The primary analysis, conducted to evaluate
the relative impact of diet treatment on these variables,
utilized repeated measures ANOVA (time × diet). Due to
fasted INS differences, we also performed a sub-set analy-
sis with subjects matched on fasted INS. To evaluate treat-
ment effects on primary outcomes controlling for changes
in body composition, an ANCOVA was used where indi-
cated. Homeostasis Model Assessment of insulin resist-
ance (HOMA1-IR) was calculated using the formula (G0 ×
I0)/22.5 [26]. Percentage change was calculated as (((post-
test)-(pre-test)/(pre-test)) × 100). A P value of < 0.05 was
considered significant. Values are presented as means ±
SEM. All data analyses were performed using SPSS version
15.0 (SPSS, Inc., Chicago, IL).Nutrition & Metabolism 2008, 5:30 http://www.nutritionandmetabolism.com/content/5/1/30
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Results
Subjects
Baseline characteristics were similar for subjects in both
treatment groups (P > 0.05) with exception of fasted INS
(P = 0.04) (Table 1).
Dietary Compliance
Daily menus were designed to provide energy for F = 7.1
MJ/d (1700 kcal) and M = 7.9 MJ/d (1900 kcal); however,
subjects were free-living and ultimately determined final
daily energy intakes. Weekly 3-d weighed food records
indicated reductions in energy intake were similar
between groups. Summary of dietary intake throughout
the 4 mo period illustrates how subjects applied the two
diets during intervention (Table 2). Consistent with
research design, PRO consumed greater protein (~1.40 g/
kg vs. ~0.77 g/kg) and less carbohydrate compared to
CHO. Total dietary fat remained similar between the two
diets. A treatment effect was present with a greater reduc-
tion in SFA (P = 0.02) and cholesterol (P = 0.001) in CHO
vs. PRO. Additionally, fiber was increased from baseline
in both groups with a trend for a greater increase in the
CHO group (PRO ~8.2% vs. CHO ~35.8%; P = 0.08).
Body Weight & Composition
Both groups decreased body weight, BMI, and fat mass
during the 4 mo treatment period. There was a trend (P =
0.07) for PRO to lose more body weight (-9.1 ± 0.9 kg)
than CHO (-6.9 ± 0.8 kg) with a corresponding reduction
in BMI (3.1 ± 0.3 kg/m2 vs. 2.4 ± 0.3 kg/m2; P = 0.07).
Changes in body composition indicated weight loss was
predominately fat mass and PRO reduced fat mass more
than CHO (-6.0 ± 0.6 kg vs. -4.4 ± 0.5 kg, respectively; P =
0.06). In addition, a greater reduction in percent fat mass
was observed in PRO vs. CHO (-8.7% vs. -5.7%; P = 0.03).
Fasted Glucose and Insulin
No effect of dietary treatment was evident in fasted
plasma glucose (PRO = -0.28 ± 0.13 mmol/L vs. CHO = -
0.52 ± 0.12 mmol/L; P = 0.19). However, differential diet
responses occurred for fasted plasma INS with a reduction
in PRO compared to an increase in CHO (P = 0.03; Figure
1A). Furthermore, after controlling for change in weight
or fat mass, the treatment effect on fasted INS favoring the
PRO group remained a trend (P = 0.07). Similarly, dietary
treatment effect on HOMA-IR produced a decrease from
baseline in the PRO group and an increase in the CHO
group producing a trend for a treatment effect (-1.1 ± 0.7
vs. +0.4 ± 0.4; P = 0.08).
Post-prandial response to the Meal Challenge
Dietary treatment did not alter plasma glucose at 1 h (P =
0.39) or 2 h (P = 0.59) post-prandial (data not shown);
however, PRO produced lower INS responses at 1 h (-
34.3% vs. -1.0%; P = 0.005; Figure 1B) and 2 h (-9.2% vs.
+46.2%; P = 0.011; Figure 1C) compared to CHO. Fur-
thermore, reduced post-prandial INS effects in PRO
remained after controlling for change in weight (1 h P =
0.013, 2 h P = 0.04) or fat mass (1 h P = 0.015, 2 h P =
0.04). As expected, in the CHO group, change in weight or
fat mass were related to change in INS at 1 h post-meal
challenge [r = 0.48 (P = 0.03) and r = 0.40 (P = 0.05)],
Table 1: Baseline body composition and metabolic 
characteristics of adult subjects 1
Group PRO (n = 25) CHO (n = 25)
Height (cm) 168.9 ± 2.3 168.2 ± 1.8
Weight (kg) 96.6 ± 3.9 94.3 ± 2.1
BMI (kg/m2) 33.8 ± 1.1 33.4 ± 0.7
Fat mass (kg) 35.2 ± 1.8 36.3 ± 1.8
Percent fat mass (%) 36.4 ± 7.7 38.2 ± 6.9
Glucose (mmol/L) 5.3 ± 0.2 5.5 ± 0.1
Insulin (pmol/L) 169.7 ± 19.7* 119.2 ± 13.7*
HOMA-IR 5.70 ± 0.74 4.09 ± 0.45
Total Cholesterol (mmol/L) 5.33 ± 0.19 5.52 ± 0.17
LDL-C (mmol/L) 3.41 ± 0.16 3.49 ± 0.13
Apolipoprotein B (mmol/L) 2.89 ± 0.15 2.80 ± 0.11
LDL-C/Apolipoprotein B ratio 1.21 ± 0.05 1.26 ± 0.04
HDL-C (mmol/L) 1.14 ± 0.07 1.27 ± 0.07
Triacylglyceride (mmol/L) 1.72 ± 0.18 1.66 ± 0.17
1 Values are means ± SEM. * Indicates group difference, P < 0.05.
Table 2: Dietary intakes for adults at baseline and during weight 
loss protocol (4 mo)1
Dietary Intake P value 2
Group PRO CHO
Energy (kJ/d)
Baseline 9952 ± 566 9147 ± 486
4 mo 6607 ± 235 5875 ± 391 >0.10
Protein (g/d)
Baseline 94.5 ± 6.2 87.9 ± 5.5
4 mo 121.4 ± 4.8 66.7 ± 2.9 <0.001
Carbohydrate (g/d)
Baseline 291.7 ± 17.4 264.9 ± 16.6
4 mo 152.6 ± 7.3 215.4 ± 12.3 <0.001
Fat (g/d)
Baseline 90.4 ± 6.4 81.5 ± 5.4
4 mo 56.2 ± 2.2 39.2 ± 2.9 >0.10
Saturated Fat (g/d)
Baseline 30.8 ± 2.4 27.6 ± 2.1
4 mo 22.6 ± 0.8 11.9 ± 1.0 <0.05
Cholesterol (mg/d)
Baseline 298.6 ± 36.5 242.8 ± 25.6
4 mo 348.8 ± 25.2 122.1 ± 12.0 <0.001
Fiber (g/d)
Baseline 19.5 ± 1.9 17.9 ± 1.6
4 mo 21.1 ± 1.9 24.3 ± 2.0 <0.10
1 Values are means ± SEM; n = 25, PRO; n = 25, CHO for the sum of 
3-d weighed records obtained at wk 4, 8, 12, and 16.
2 P values represent time × diet interaction after 4 mo. No significant 
baseline differences were present.Nutrition & Metabolism 2008, 5:30 http://www.nutritionandmetabolism.com/content/5/1/30
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Change in insulin concentration Figure 1
Change in insulin concentration. Change in insulin concentration, pmol/L, from baseline to 4 mo at fasted (A) 1 hr (B) and 
2 hr (C) post-prandial in response to the meal challenge for adults consuming either the PRO (n = 25, gray bar) or CHO (n = 
25, white bar) diet. Values are means ± SEM. *Indicates time × diet interaction P < 0.05.
$
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respectively; however, the relation was not present at 2 h
post-meal challenge [r = 0.28 (P = 0.18) and r = 0.30 (P =
0.14)]. Relations of the changes in the PRO group were
not as robust with the strongest relation being an r = 0.23
between change in weight and change in INS at 2 h post-
meal challenge (P > 0.27).
Baseline insulin group difference: ANCOVA and matched 
subset analysis
Due to differences in fasted plasma INS between treat-
ment groups after randomization (P = 0.04), we utilized a
subset analysis on treatment groups matched on fasted
plasma INS at baseline (n = 22, PRO = 139.2 ± 14.3 pmol/
L; n = 22, CHO = 129.3 ± 13.7 pmol/L; P = 0.47) and with
an ANCOVA controlling for baseline INS. Within the INS
matched subset, the diet effect on fasted INS after 4 mo
was no longer evident (P  = 0.31); however, favorable
effects of the PRO diet remained post-prandially at 1 h
(PRO = -299.5 ± 69.7 vs. CHO = -165.0 ± 74.2; P = 0.02)
and 2 h (PRO = -126.0 ± 57.1 vs. CHO = 9.2 ± 32.4; P =
0.03). Likewise, the ANCOVA results supported favorable
post-prandial effects of the PRO diet (1 h, P = 0.02; 2 h, P
= 0.04, respectively).
Serum Lipids
At randomization serum lipid concentrations were similar
among groups (Table 1). After 4 mo, serum lipid profiles
changed in both groups; however, the patterns of change
were affected by diet. There was a trend for greater
decreases in TC in the CHO group compared to the PRO
group (-0.39 ± 0.09 mmol/L vs. -0.13 ± 0.13 mmol/L; P =
0.09). LDL-C, Figure 2A, was reduced in the CHO group
compared to an increase in the PRO group (-6.5% vs.
+4.9%; P  = 0.046). Both treatment groups exhibited a
small (~11%) decrease in apolipoprotein B (ApoB) con-
centration at 16 wks that was not significantly different
from baseline for the PRO or CHO group (P = 0.61; -0.41
± 0.12 mmol/L vs. -0.33 ± 0.10 mmol/L). However, the
decrease in ApoB coupled with the decrease in LDL-C in
the CHO group produced a greater increase in the LDL-C/
ApoB ratio, Figure 2B, in the PRO group compared to the
CHO group (+22.0% vs. +7.3%; P = 0.045). HDL-C con-
centrations, Figure 2C, changed in opposite directions
with an increase in PRO (+6.9%) and a decrease in CHO
(-1.7%; P = 0.045). Reductions in TAG, Figure 2D, were
greater in the PRO group (-26.8%), than in the CHO
group (-7.0%; P = 0.01), an effect that remained after con-
trolling for changes in both weight (P = 0.04) and fat mass
(P = 0.04). When further exploring change in weight or fat
mass in relation to this primary lipid outcome, there was
a relation between TAG and weight and fat mass in the
PRO group [r = 0.41 (P = 0.04) and r = 0.34 (P = 0.097)]
respectively; however no relation was present in the CHO
group [r = 0.019 and r = 0.029 (both P > 0.93)].
Discussion
The PRO diet produced greater reductions in fat mass and
a trend for greater weight loss compared to the CHO diet.
Furthermore, the PRO diet produced greater improve-
ment in features of dyslipidemia and post-prandial INS
response. In support of our hypothesis, this study demon-
strates that free-living overweight or obese individuals
have greater reductions in risk factors for CVD and T2DM
by utilizing a PRO weight loss diet instead of a conven-
tional CHO diet. Specifically, the PRO diet modulates
post-prandial INS and fasted TAG, two key risk factors and
early markers for MetS, T2DM, and CVD.
The importance of these two markers, post-prandial INS
and fasted TAG, is beginning to be appreciated in the clin-
ical setting. Loss of post-prandial glucose control has been
implicated as the first step of deterioration in individuals
with MetS and T2DM. Deterioration of glycemic regula-
tion often first appears as compensatory hyperinsuline-
mia seen post-prandial to a meal to maintain glucose
uptake into cells and normal homeostasis [27]. In addi-
tion, dietary carbohydrate, specifically simple sugars, pro-
mote atherogenic dyslipidemia, mostly resulting from
effects on TAG metabolism [9,28], thereby increasing risk
of CVD.
In the current study, post-prandial INS response was
determined after a mixed meal challenge similar in con-
cept to that of an oral glucose tolerance test. The post-
prandial response demonstrated a significant decrease in
1 h and 2 h INS in the PRO treatment (see Figure 1) which
remained significant irrespective of weight or fat mass
reduction. This positive outcome in response to the PRO
diet is similar to results reported for other reduced carbo-
hydrate diets [5,15]; however, the present study evaluated
free-living overweight/obese individuals without diabetes
and dietary fat was similar in the two dietary protocols.
Regarding the most similar population, subjects with
mild, untreated T2DM, the net mean 24 h integrated insu-
lin and glucose area response was significantly decreased
after 5 wk on a low carbohydrate diet compared to a high
carbohydrate diet [15]. Moreover, our previous study uti-
lizing a highly controlled diet design in which meals were
provided to subjects resulted in similar adaptations in the
post-prandial INS response [14]. This accumulating liter-
ature indicates that PRO diets are effective in improving
post-prandial INS responses in free-living populations,
supporting use of this diet treatment in reducing risk for
MetS, T2DM, and CVD.
Likewise, fasted INS demonstrated a favorable response in
PRO compared to CHO as seen by the significant decrease
in fasted INS from baseline (see Figure 1) in addition to a
decreasing trend in HOMA-IR. These two parameters
along with the post-prandial INS responses suggest anNutrition & Metabolism 2008, 5:30 http://www.nutritionandmetabolism.com/content/5/1/30
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Fasted serum lipid concentrations Figure 2
Fasted serum lipid concentrations. Change in fasted serum lipid concentrations, mmol/L, of LDL-C (A), LDL-C/ApoB 
ratio (B), HDL-C (C), and triacylglyceride (D), from baseline to 4 mo for adults consuming either the PRO (n = 25) or CHO 
(n = 25) diet. Values are each individual's data point (X) with means (black line bar) within each group. All outcomes had a time 
× diet interaction P < 0.05 between group means.Nutrition & Metabolism 2008, 5:30 http://www.nutritionandmetabolism.com/content/5/1/30
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increase in INS sensitivity in individuals consuming the
PRO diet. These findings support the hypothesis that the
macronutrient composition of weight loss diets, specifi-
cally exchanging protein for carbohydrate, minimize need
for peripheral glucose uptake and improve insulin sensi-
tivity (16).
High TAG, low HDL-C and high small dense LDL-C are
components of atherogenic dyslipidemia commonly seen
with MetS which also contributes to risk for CVD [29].
Consistent with reduced post-prandial INS, the PRO diet
produced greater improvement in dyslipidemia. Serum
TAG reduction was favored in PRO over CHO (see Figure
2) which was in agreement with previous studies in our
lab [11,19] in addition to other clinical studies investigat-
ing weight loss protocols with reduction in dietary carbo-
hydrate [5,9,12,13,15,30,31]. HDL-C increases in PRO
(see Figure 2) are also in agreement with previous research
using reduced carbohydrate diets [11,30-32]. Reductions
in LDL-C in the CHO diet likely reflect consumption of
half the amount of cholesterol and saturated fat compared
to PRO due to increased consumption of animal protein
sources in PRO although both lipid and saturated fat
amounts decreased from baseline in both groups (see
Table 2). Additionally, previous research has shown that
LDL-C particle size increases with low carbohydrate diets,
which is indicative of larger non-atherogenic LDL-C parti-
cles [9,31,33,34]. Using the LDL-C/ApoB ratio as an indi-
cation of particle size [35], this study found a significant
increase in PRO compared to CHO (see Figure 2) suggest-
ing a benefit of PRO on LDL-C particle size.
This study confirms that reducing dietary carbohydrates
produces improvements in characteristics of dyslipidemia
and insulin sensitivity [36]. Reducing carbohydrate intake
can be achieved through energy restriction or replacement
of carbohydrates with protein [9,11] or fat [10,31,33,34].
The relative merit of substitution with protein or fat
remains unknown. McAuley et al [10] reported that
changes in TAG, HDL-C and fasting insulin were similar
with high protein or high fat diets but found greater
improvements in LDL-C with the high protein diet. Like-
wise, PRO diets may have greater effects on satiety [17]
and body composition [17,37]; however well-designed
studies are required to elucidate this question.
This study is not without limitations. First, it must be
taken into consideration that although we matched
groups on fasted glucose, we did not match on fasted INS
resulting in a statistical difference at baseline in this varia-
ble. To address this situation, we performed a subset anal-
ysis matching groups on fasted INS and used an ANCOVA
controlling for baseline INS at 1 h and 2 h. These second-
ary analyses attenuated differences in fasted INS response
to dietary treatment at 4 mo; however differences in post-
prandial INS after the meal challenge remained. Second,
exercise was not a mandatory part of the weight loss regi-
men and subjects averaged less than 100 min/wk of added
exercise. Finally, subjects were free-living individuals and
ultimate food choices were made at their discretion.
Conclusion
In summary, this study evaluated diet specific outcomes
of free-living overweight or obese subjects without diabe-
tes. Subjects on either isocaloric diet complied with the
prescribed protocol and reduced both weight and fat
mass; however, the PRO diet was better overall than the
CHO diet for risk reduction of metabolic disease beyond
that of weight management. Greater improvements in
post-prandial INS were demonstrated in subjects consum-
ing the PRO diet with effects observed at 1 h and 2 h after
a meal challenge. Additionally, fasted INS further sup-
ported the decrease in HOMA-IR for improvement in INS
sensitivity in the PRO group. Features of atherogenic dys-
lipidemia improved significantly in the PRO group as
demonstrated by decreases in TAG and increases in HDL-
C and LDL-C/ApoB ratio. Collectively, these results sup-
port use of PRO diets with moderate carbohydrate, mod-
erate protein over conventional CHO diets with high
carbohydrate, low protein for decreasing risk for obesity,
and more importantly, MetS, T2DM, and CVD. Future
research is needed to 1) define optimal diet composition
for individuals varying in risk for metabolic disease (e.g.
hypercholesterolemia vs. MetS and 2) determine cellular
mechanisms by which differing macronutrient diets pro-
duce these favorable health outcomes.
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